March 10, 2026Amsterdam, the Netherlands, and Las Vegas, USA –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today ...

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction ...

The decision by Judge Brian Murphy immediately halted implementation of a series of measures imposed by the Trump ...

The MarketWatch News Department was not involved in the creation of this content.-- Nadofaragene firadenovec-vncg received an NCCN Category 2A recommendation for patients with pap ...

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced positive, top-line results from the pivotal Phase 3 ADorable-1 trial evaluating efficacy and ...

OneDose® secures funding to enhance emergency care platform led by M25 with participation from CoFound Partners. We’re ...

Boston-based consulting firm publishes interactive planning tools covering health cost projections, benefits ROI, and ...

The March session of the University of Iowa’s AI Lightning Talks, themed “AI in Research: Inside Faculty Workflows,” featured staff and faculty who have been implementing artificial intelligence into ...

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that a moderated ...

The FDA has approved secukinumab (Cosentyx; Novartis) for the treatment of pediatric patients 12 years and older with moderate to severe hidradenitis suppurativa (HS), the company announced. 1 The ...

UALink data exchange and control; AI sovereignty; 3D-IC thermal behavior; UART security; SystemVerilog coverage extensibility.